Baker's yeast as a tool for the development of antifungal drugs which target cell integrity - an update

Autor(en): Heinisch, Juergen J.
Stichwörter: AGENTS; bioinformatics; CANDIDA-ALBICANS; cell wall integrity pathway; CRYPTOCOCCUS-NEOFORMANS; genetic screens; INHIBITORS; LARGE-SCALE; MODE; Pharmacology & Pharmacy; plasma membrane; PROTEIN; SACCHAROMYCES-CEREVISIAE; SCREEN; WALL BIOSYNTHESIS
Erscheinungsdatum: 2008
Herausgeber: TAYLOR & FRANCIS LTD
Journal: EXPERT OPINION ON DRUG DISCOVERY
Volumen: 3
Ausgabe: 8
Startseite: 931
Seitenende: 943
Zusammenfassung: 
Background: The yeast Saccharomyces cerevisiae has developed into a general eukaryotic model system because of the widespread use of genetic manipulation and the availability of whole genome approaches. it can serve as a reference for gene and protein functions in pathogenic fungi. Moreover, high-throughput drug screens developed in baker's yeast are slowly being adapted to these fungi. This is of particular interest in the light of increasing numbers of fungal human and plant diseases. Objective: This review summarizes briefly the variety of new approaches for drug development and explains resistance mechanisms that are based on modern yeast genetics. Methods: Concentrating on the cell envelope, the principles underlying different screens are explained and examples for drugs under investigation and already in use are given. Conclusion: In recent years the potency of yeast genetics for drug development has been extended in an unprecedented scale. Nevertheless, the constant advent in this field, in combination with bioinformatic approaches, indicates that today we can only see the tip of the iceberg of the discoveries to be made.
ISSN: 17460441
DOI: 10.1517/17460441.3.8.931

Show full item record

Page view(s)

1
Last Week
0
Last month
0
checked on Mar 3, 2024

Google ScholarTM

Check

Altmetric